PSMA binder-2 is a ligand for PSMA and can be used to synthesize Ac-PSMA-trillium, a PSMA-targeting compound with improved PSMA binding affinity and pharmacokinetic properties. Upon modification with different radioisotopes, PSMA ligands exhibit various biological applications: when labeled with 111In, it serves as a DOTA chelator and imaging agent; when labeled with 225Ac, it functions as a Macropa chelator for targeted radionuclide therapy (TRT) in the study of metastatic castration-resistant prostate cancer (mCRPC).